sample	tissue	condition	fpkm
SRR797917	embryo	pbx2/4-MO and prdm1-/-	4.7548900000000005
SRR797914	embryo	pbx2/4-MO	3.82535
SRR797911	embryo	prdm1-/-	2.29316
SRR797908	embryo	normal	2.15272
SRR1021213	sphere stage	normal	0.859258
SRR1021215	sphere stage	Mzeomesa	0.4996
SRR886457	512 cell	4-thio-UTP metabolic labeling	0.318441
SRR658545	6 somite	Gata6 morphant	0.306208
SRR658535	bud	Gata5 morphant	0.302683
SRR1035984	13 hpf	normal	0.29331799999999997
SRR372796	bud	normal	0.29087199999999996
SRR527840	24hpf	normal	0.224735
SRR658543	6 somite	Gata5 morphan	0.214252
SRR658539	bud	Gata5/6 morphant	0.166921
SRR1035981	13 hpf	rx3+/+ or rx3+/-	0.165082
SRR658541	6 somite	normal	0.14284000000000002
SRR658533	bud	normal	0.136798
SRR535986	larvae	nhsl1b mut	0.0896035
SRR1035978	13 hpf	rx3-/-	0.0837135
SRR658537	bud	Gata6 morphant	0.07355830000000001
SRR800049	sphere stage	control treatment	0.0634524
SRR527844	24hpf	normal	0.059262800000000004
SRR372793	shield	normal	0.0473827
SRR527836	24hpf	normal	0.045152
SRR514028	retina	control morpholino	0.0412726
SRR594771	endothelium	normal	0.031123
SRR1299128	caudal fin	Three days time after treatment	0.029337900000000004
SRR1708343	embryo	MUTAS	0.024774099999999997
ERR594417	retina	normal	0.0182536
SRR372791	dome	normal	0.0140118
SRR658547	6 somite	Gata5/6 morphant	0.011228499999999999
SRR372798	28 hpf	normal	0.008946299999999999
SRR1049946	embryo	transgenic TgOMP-Gal4 and UAS-GCaMP1.6 and treated with DMSO	0.0088555
SRR372787	2-4 cell	normal	0.0066687